STAT5B Suppresses Ferroptosis by Promoting DCAF13 Transcription to Regulate p53/xCT Pathway to Promote Mantle Cell Lymphoma Progression

References

• Jain P, Wang M. Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management. Am J Hematol. 2019;94(6):710–725. doi:10.1002/ajh.25487
   PubMed Web of Science ®Google Scholar
• Maddocks K. Update on mantle cell lymphoma. Blood. 2018;132(16):1647–1656. doi:10.1182/blood-2018-03-791392
   PubMed Web of Science ®Google Scholar
• Navarro A, Beà S, Jares P, et al. Molecular pathogenesis of mantle cell lymphoma. Hematol Oncol Clin North Am. 2020;34(5):795–807. doi:10.1016/j.hoc.2020.05.002
   PubMed Web of Science ®Google Scholar
• Verhoeven Y, Tilborghs S, Jacobs J, et al. The potential and controversy of targeting STAT family members in cancer. Semin Cancer Biol. 2020;60:41–56. doi:10.1016/j.semcancer.2019.10.002
   PubMed Web of Science ®Google Scholar
• Maurer B, Kollmann S, Pickem J, et al. STAT5A and STAT5B—twins with different personalities in hematopoiesis and leukemia. Cancers. 2019;11(11):1726. doi:10.3390/cancers11111726
   PubMed Web of Science ®Google Scholar
• Erb H, Bodenbender J, Diehl T, et al. Overcoming enzalutamide-resistance by inhibition of the transcription factor Stat5b in prostate cancer. Eur Urol Suppl. 2019;18(1):e1345. doi:10.1016/S1569-9056(19)30973-X
   Google Scholar
• Kollmann S, Grausenburger R, Klampfl T, et al. A STAT5B-CD9 axis determines self-renewal in hematopoietic and leukemic stem cells. Blood. 2021;138(23):2347–2359. doi:10.1182/blood.2021010980
   PubMed Web of Science ®Google Scholar
• Sumiyoshi H, MATSUSHITA A, NAKAMURA Y, et al. Suppression of STAT5b in pancreatic cancer cells leads to attenuated gemcitabine chemoresistance, adhesion and invasion. Oncol Rep. 2016;35(6):3216–3226. doi:10.3892/or.2016.4727
   PubMed Web of Science ®Google Scholar
• Subramaniam D, Angulo P, Ponnurangam S, et al. Suppressing STAT5 signaling affects osteosarcoma growth and stemness. Cell Death Dis. 2020;11(2):149. doi:10.1038/s41419-020-2335-1
   PubMed Web of Science ®Google Scholar
• Zhang W, Liang X, Gong Y, et al. The signal transducer and activator of transcription 5B (STAT5B) gene promotes proliferation and drug resistance of human mantle cell lymphoma cells by activating the akt signaling pathway. Med Sci Monit. 2019;25:2599–2608. doi:10.12659/MSM.914934
   PubMed Web of Science ®Google Scholar
• Sun Y, Chen P, Zhai B, et al. The emerging role of ferroptosis in inflammation. Biomed Pharmacother. 2020;127:110108. doi:10.1016/j.biopha.2020.110108
   PubMed Web of Science ®Google Scholar
• Zhang Y, Swanda RV, Nie L, et al. mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation. Nat Commun. 2021;12(1):1589. doi:10.1038/s41467-021-21841-w
   PubMed Web of Science ®Google Scholar
• Tang Z, Jiang W, Mao M, et al. Deubiquitinase USP35 modulates ferroptosis in lung cancer via targeting ferroportin. Clin Transl Med. 2021;11(4):e390. doi:10.1002/ctm2.390
   PubMed Web of Science ®Google Scholar
• Wohlhieter CA, Richards AL, Uddin F, et al. Concurrent mutations in STK11 and KEAP1 promote ferroptosis protection and SCD1 dependence in lung cancer. Cell Rep. 2020;33(9):108444. doi:10.1016/j.celrep.2020.108444
   PubMed Web of Science ®Google Scholar
• Luo Y, Xiang W, Liu Z, et al. Functional role of the SLC7A11-AS1/xCT axis in the development of gastric cancer cisplatin-resistance by a GSH-dependent mechanism. Free Radic Biol Med. 2022;184:53–65. doi:10.1016/j.freeradbiomed.2022.03.026
   PubMed Web of Science ®Google Scholar
• Dai L, Cao Y, Chen Y, et al. Genomic analysis of xCT-mediated regulatory network: identification of novel targets against AIDS-associated lymphoma. Oncotarget. 2015;6(14):12710–12722. doi:10.18632/oncotarget.3710
   PubMedGoogle Scholar
• Guan Z, et al. Tanshinone IIA induces ferroptosis in gastric cancer cells through p53-mediated SLC7A11 down-regulation. Biosci Rep. 40(8):1.
   Google Scholar
• Zhang Y-H, Gao L-M, Xiang X-Y, et al. Prognostic value and computer image analysis of p53 in mantle cell lymphoma. Ann Hematol. 2022;101(10):2271–2279. doi:10.1007/s00277-022-04922-8
   PubMed Web of Science ®Google Scholar
• Cheng Y, Hao Y, Zhang A, et al. Persistent STAT5-mediated ROS production and involvement of aberrant p53 apoptotic signaling in the resistance of chronic myeloid leukemia to imatinib. Int J Mol Med. 2018;41(1):455–463. doi:10.3892/ijmm.2017.3205
   PubMed Web of Science ®Google Scholar
• Laka K, Mapheto KBF, Mbita Z. Selective in vitro cytotoxicity effect of drimia calcarata bulb extracts against p53 mutant HT-29 and p53 wild-type Caco-2 colorectal cancer cells through STAT5B regulation. Toxicol Rep. 2021;8:1265–1279. doi:10.1016/j.toxrep.2021.06.015
   PubMed Web of Science ®Google Scholar
• Manzoor H, Zahid H, Emerling CA, et al. A biallelic variant of DCAF13 implicated in a neuromuscular disorder in humans. Eur J Hum Genet. 2023;31(6):629–637. doi:10.1038/s41431-023-01319-7
   PubMed Web of Science ®Google Scholar
• Wei S, Xing J, Chen J, et al. DCAF13 inhibits the p53 signaling pathway by promoting p53 ubiquitination modification in lung adenocarcinoma. J Exp Clin Cancer Res. 2024;43(1):3. doi:10.1186/s13046-023-02936-2
   PubMed Web of Science ®Google Scholar
• Zhang S, Bai X, Li F, et al. UTP23 functions in breast cancer progression and predicts poor prognosis of luminal a breast cancer. Clin Breast Cancer. 2024;24(1):e20–e30.e6. doi:10.1016/j.clbc.2023.09.019
   PubMed Web of Science ®Google Scholar
• Silkenstedt E, Linton K, Dreyling M. Mantle cell lymphoma - advances in molecular biology, prognostication and treatment approaches. Br J Haematol. 2021;195(2):162–173. doi:10.1111/bjh.17419
   PubMed Web of Science ®Google Scholar
• Robak T, et al. Mantle cell lymphoma: therapeutic options in transplant-ineligible patients. Leuk Lymphoma. 2019;60(11):2622–2634. doi:10.1080/10428194.2019.1605511
   PubMed Web of Science ®Google Scholar
• Hayden PJ, Roddie C, Bader P, et al. Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA). ann oncol. Annals of Oncology: Official Journal of the European Society for Medical Oncology. 2022;33(3):259–275. doi:10.1016/j.annonc.2021.12.003
   PubMed Web of Science ®Google Scholar
• Visco C, Di Rocco A, Evangelista A, et al. Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study. Leukemia. 2021;35(3):787–795. doi:10.1038/s41375-020-01013-3
   PubMed Web of Science ®Google Scholar
• Kim U, Shin HY. Genomic mutations of the STAT5 transcription factor are associated with human cancer and immune diseases. Int J Mol Sci. 2022;23(19):1.
   Web of Science ®Google Scholar
• Villarino AV, Kanno Y, Ferdinand JR, et al. Mechanisms of Jak/STAT signaling in immunity and disease. J Immunol. 2015;194(1):21–27. doi:10.4049/jimmunol.1401867
   PubMed Web of Science ®Google Scholar
• Morris R, Kershaw NJ, Babon JJ. The molecular details of cytokine signaling via the JAK/STAT pathway. Protein Sci. 2018;27(12):1984–2009. doi:10.1002/pro.3519
   PubMed Web of Science ®Google Scholar
• Rani A, Murphy JJ. STAT5 in cancer and immunity. J Interferon Cytokine Res. 2016;36(4):226–237. doi:10.1089/jir.2015.0054
   PubMed Web of Science ®Google Scholar
• Villarino AV, Kanno Y, O’Shea JJ. Mechanisms and consequences of Jak–STAT signaling in the immune system. Nat Immunol. 2017;18(4):374–384. doi:10.1038/ni.3691
   PubMed Web of Science ®Google Scholar
• Bagger FO, et al. BloodSpot: a database of gene expression profiles and transcriptional programs for healthy and malignant haematopoiesis. Nucleic Acids Res. 2016;44(D1):D917–24.
   PubMed Web of Science ®Google Scholar
• Hsu MY, Mina E, Roetto A, et al. Iron: an essential element of cancer metabolism. Cells. 2020;9(12):2591. doi:10.3390/cells9122591
   PubMed Web of Science ®Google Scholar
• Diallo A, Deschasaux M, Partula V, et al. Dietary iron intake and breast cancer risk: modulation by an antioxidant supplementation. Oncotarget. 2016;7(48):79008–79016. doi:10.18632/oncotarget.12592
   PubMedGoogle Scholar
• Komoto K, Nomoto T, El Muttaqien S, et al. Iron chelation cancer therapy using hydrophilic block copolymers conjugated with deferoxamine. Cancer Sci. 2021;112(1):410–421. doi:10.1111/cas.14607
   PubMed Web of Science ®Google Scholar
• Yu H, Yang C, Jian L, et al. Sulfasalazine‑induced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor. Oncol Rep. 2019;42(2):826–838. doi:10.3892/or.2019.7189
   PubMed Web of Science ®Google Scholar
• Liang C, Zhang X, Yang M, et al. Recent progress in ferroptosis inducers for cancer therapy. Adv Mater. 2019;31(51):e1904197. doi:10.1002/adma.201904197
   PubMed Web of Science ®Google Scholar
• Li C, Tian Y, Liang Y, et al. Circ_0008035 contributes to cell proliferation and inhibits apoptosis and ferroptosis in gastric cancer via miR-599/EIF4A1 axis. Cancer Cell Int. 2020;20(1):84. doi:10.1186/s12935-020-01168-0
   PubMed Web of Science ®Google Scholar
• Tang X, Ding H, Liang M, et al. Curcumin induces ferroptosis in non-small-cell lung cancer via activating autophagy. Thorac Cancer. 2021;12(8):1219–1230. doi:10.1111/1759-7714.13904
   PubMed Web of Science ®Google Scholar
• Chen H, Cao L, Han K, et al. Patulin disrupts SLC7A11-cystine-cysteine-GSH antioxidant system and promotes renal cell ferroptosis both in vitro and in vivo. Food Chem Toxicol. 2022;166:113255. doi:10.1016/j.fct.2022.113255
   PubMed Web of Science ®Google Scholar
• Eichelmann AK, Mayne GC, Chiam K, et al. Mutant p53 Mediates Sensitivity to Cancer Treatment Agents in Oesophageal Adenocarcinoma Associated with MicroRNA and SLC7A11 Expression. Int J Mol Sci. 2021;22(11):5547. doi:10.3390/ijms22115547
   PubMed Web of Science ®Google Scholar
• Luo Y, Gao X, Zou L, et al. Bavachin induces ferroptosis through the STAT3/P53/SLC7A11 axis in osteosarcoma cells. Oxid Med Cell Longev. 2021;2021:1783485. doi:10.1155/2021/1783485
   PubMed Web of Science ®Google Scholar
• Zhou X, Zou L, Chen W, et al. Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer. Pharmacol Res. 2021;164:105305. doi:10.1016/j.phrs.2020.105305
   PubMed Web of Science ®Google Scholar
• Joung YH, Lim E-J, Kim M-S, et al. Enhancement of hypoxia-induced apoptosis of human breast cancer cells via STAT5b by momilactone B. Int J Oncol. 2008;33(3):477–484.
   PubMed Web of Science ®Google Scholar
• Moyama C, FUJITA M, OKAMOTO H, et al. Myb repression mediates stat5b-knockdown-induced apoptosis and inhibits proliferation of glioblastoma stem cells. Cancer Genomics Proteomics. 2023;20(2):195–202. doi:10.21873/cgp.20374
   PubMed Web of Science ®Google Scholar
• Liu J, Li H, Mao A, et al. DCAF13 promotes triple-negative breast cancer metastasis by mediating DTX3 mRNA degradation. Cell Cycle. 2020;19(24):3622–3631. doi:10.1080/15384101.2020.1859196
   PubMed Web of Science ®Google Scholar
• Wei S, Lu K, Xing J, et al. A multidimensional pan-cancer analysis of DCAF13 and its protumorigenic effect in lung adenocarcinoma. FASEB j. 2023;37(4):e22849. doi:10.1096/fj.202201022RRR
   PubMed Web of Science ®Google Scholar
• Cao J, Hou P, Chen J, et al. The overexpression and prognostic role of DCAF13 in hepatocellular carcinoma. Tumour Biol. 2017;39(6):1010428317705753. doi:10.1177/1010428317705753
   Google Scholar
• Zhang J, Zhang Y-L, Zhao L-W, et al. The CRL4-DCAF13 ubiquitin E3 ligase supports oocyte meiotic resumption by targeting PTEN degradation. Cell Mol Life Sci. 2020;77(11):2181–2197. doi:10.1007/s00018-019-03280-5
   PubMed Web of Science ®Google Scholar
• Huang S, Liu Y, Chen Z, et al. PIK-75 overcomes venetoclax resistance via blocking PI3K-AKT signaling and MCL-1 expression in mantle cell lymphoma. Am J Cancer Res. 2022;12(3):1102–1115.
   PubMed Web of Science ®Google Scholar